US firm Biocoat Incorporated secures new patent for non-PFAS inner diameter coating

image credit- shutterstock

Pennsylvania's Biocoat Incorporated, a leader in the development, manufacturing, and application of hydrophilic coatings for medical devices, announced the issuance of a patent for "Lumen Coating Method and Apparatus." This new patent covers a thermal cure hydrophilic coating technology specifically designed for application to the lumen, or inner diameter. This technology is commonly applied in catheters and other medical devices used in multiple medical specialties, including cardiology and neurology.

The newly patented technology represents a significant advancement in medical device coatings, offering the industry a high-performance, non-PFAS (per- and polyfluoroalkyl substances) alternative. As concerns over the environmental and health impacts of PFAS continue to grow, Biocoat's innovation provides a safer, more sustainable solution for medical device manufacturers without compromising on quality or performance.

The new coating technology delivers excellent lubricity, durability, and low particulate counts, all while utilizing lower curing temperatures such that common polymer substrates are not impacted. This hydrophilic, non-PFAS option can boost the industry's shift towards greener and more environmentally friendly materials, contributing to the development of safer medical products for patients worldwide.